Biocryst Pharmaceuticals buy Needham & Company LLC
Start price
07.05.24
/
50%
€4.98
Target price
07.05.25
€11.13
Performance (%)
19.66%
Price
31.05.24
€5.96
Summary
This prediction is currently active. The BUY prediction by Needham___Company_LL currently has a performance of 19.66%. This prediction currently runs until 07.05.25. The prediction end date can be changed by Needham___Company_LL at any time. Needham___Company_LL has 50% into this predictionPerformance without dividends (%)
Name | 1w |
---|---|
Biocryst Pharmaceuticals | 5.339% |
iShares Core DAX® | -0.552% |
iShares Nasdaq 100 | -1.415% |
iShares Nikkei 225® | -0.877% |
iShares S&P 500 | -0.415% |
Comments by Needham___Company_LL for this prediction
In the thread Biocryst Pharmaceuticals diskutieren
BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $12.00 price target on the stock.
Ratings data for BCRX provided by MarketBeat
Stopped prediction by Needham___Company_LL for Biocryst Pharmaceuticals
Biocryst Pharmaceuticals
Start price
Target price
Perf. (%)
€6.00
08.01.24
08.01.24
€10.95
08.01.25
08.01.25
-0.70%
31.05.24
31.05.24
Biocryst Pharmaceuticals
Start price
Target price
Perf. (%)
€5.70
06.11.23
06.11.23
€11.17
06.11.24
06.11.24
4.53%
31.05.24
31.05.24
Biocryst Pharmaceuticals
Start price
Target price
Perf. (%)
€6.47
03.08.23
03.08.23
€10.96
03.08.24
03.08.24
-7.86%
31.05.24
31.05.24
Biocryst Pharmaceuticals
Start price
Target price
Perf. (%)
€6.67
20.04.23
20.04.23
€12.77
20.04.24
20.04.24
-38.50%
21.04.24
21.04.24